AstraZeneca Plc is spinning off a company to develop drugs for immune disorders with as much as $250 million from a group of investors.
from Bloomberg http://ift.tt/2t9g2zF
Subscribe to:
Post Comments (Atom)
Their goal is a peaceful retirement. Up to half a million dollars in student loans is standing in the way.
High student-loan balances are weighing on borrowers' retirement goals. Courtesy of Amye Cooley, Jordan Hendrickson Changes to fede...
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
The Bell V-280 Valor was selected as the Army's future long-range assault aircraft in 2022. Photo courtesy of Bell The US Army desi...
-
Student-loan borrowers said they're worried about higher payments without the SAVE plan. Aaron Hawkins/Getty Images/iStockphoto Tru...
No comments:
Post a Comment